bosentan anhydrous has been researched along with mocetinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, KJ; Hickey, MJ; Knight, KR; Lepore, DA; Morrison, WA; Stewart, AG | 1 |
| Cetinel, S; Ghandour, S; Kurtel, H | 1 |
| Cetinel, S; Deniz, M; Kurtel, H | 1 |
| Chilakapati, DR; Chilakapati, SR; Kanala, JR; Serasanambati, M; Vissavajjhala, P | 1 |
| Alves-Filho, JC; Casagrande, R; Cunha, FQ; Cunha, TM; Fattori, V; Navarro, SA; Pinho-Ribeiro, FA; Serafim, KG; Verri, WA; Zarpelon, AC | 1 |
5 other study(ies) available for bosentan anhydrous and mocetinostat
| Article | Year |
|---|---|
Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle.
Topics: Animals; Blood Pressure; Bosentan; Carbon; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Hindlimb; Male; Muscle, Skeletal; Perfusion; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sulfonamides; Time Factors; Water | 2001 |
Endothelin-3 induced mesenteric vasoconstriction and PMN infiltration in the rat small intestine: role of endothelin receptors.
Topics: Animals; Antihypertensive Agents; Azepines; Bosentan; Edetic Acid; Endothelin-3; Female; Intestinal Mucosa; Intestine, Small; Leukocytes, Mononuclear; Male; Mesenteric Arteries; Mucous Membrane; Oligopeptides; Peroxidase; Piperidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Time Factors | 2004 |
Blood flow alterations in TNBS-induced colitis: role of endothelin receptors.
Topics: Animals; Antihypertensive Agents; Azepines; Bosentan; Colitis; Inflammation; Male; Mesenteric Arteries; Mucous Membrane; Oligopeptides; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Regional Blood Flow; Sulfonamides; Time Factors; Trinitrobenzenesulfonic Acid | 2004 |
Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Topics: Actins; Animals; Anti-Inflammatory Agents; Bleomycin; Bosentan; Catalase; Collagen Type I; Collagen Type II; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Lung; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Oxidative Stress; Peroxidase; Pneumonia; Pulmonary Edema; RNA, Messenger; Sulfonamides; Superoxide Dismutase; Time Factors | 2015 |
Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Bosentan; Cytokines; Endothelin Receptor Antagonists; Hyperalgesia; Leukocytes; Male; Mice; Pain; Peritoneal Cavity; Peroxidase; Skin; Spinal Cord; Sulfonamides; Superoxides | 2015 |